Request A Free Case Review From A NAION Injury Lawyer NAION Eye Injury Lawsuit & Settlement Cases NAION lawsuit and settlement cases potentially being investigated include claims of individuals who, after taking Ozempic, Wegovy or other semaglutide or GLP-1 medications to treat diabetes or obesity, were diagnosed with non-arteritic anterior ischemic optic neuropathy: Non-arteritic anterior ischemic optic neuropathy NAION Non-arteritic AION Ischemic optic neuropathy Papillitis ischemica Anterior ischemic optic neuropathy (AION): Eye stroke Optic disc infarction Disc edema with ischemic etiology Optic nerve damage Sudden vision loss Blindness Other eye injury lawsuit cases If you or someone you love took Ozempic, Wegovy, or other GLP-1 medications and were later diagnosed with NAION, you may qualify to recover money from an Ozempic NAION lawsuit or settlement case
The Lirag group was administered liraglutide (Novo Nordisk, Copenhagen, Denmark) at a dose of 200 g/kg/12 h for 8 weeks, as previously described (Hayes et al., 2011)
What lifestyle changes improve results with GLP-1 injections for weight loss
High-fiber intake is positively associated with SHBG levels in older men, whereas high-protein diets have the opposite effect [281]
Chronic kidney disease and poor outcomes in ischemic stroke: is impaired cerebral autoregulation the missing link
Our team is on standby to help today
